TNBC is molecularly defined as a breast cancer subtype that is estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and does not overexpress human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is breast carcinoma.